MARIETTA, Ga.--(BUSINESS WIRE)--Jan. 19, 2006--Solvay Pharmaceuticals announced today the promotion of Harold H. Shlevin, Ph.D. to Global Senior Vice President of the newly formed global Regulatory, External Affairs, Safety and Quality Strategies (RESQS) organization effective Jan. 1, 2006 reporting to Dr. Werner Cautreels, global CEO of Solvay Pharmaceuticals. Shlevin formerly served as President and CEO of Solvay Pharmaceuticals, Inc., in the United States and is succeeded by Laurence Downey, MD. Shlevin will continue to serve as a member of the board of directors for the U.S. pharmaceuticals organization and will assume additional responsibilities as a member of both the executive directors committee and the board of directors for the global Solvay Pharmaceuticals organization.
